Compare, Analyse ASTRAZENECA PHARMA with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs TEVA PHARMA (Israel) - Comparison Results

ASTRAZENECA PHARMA     Change

AstraZeneca Pharma India Limited (APIL) is a 90% subsidiary of the UK based AstraZeneca Pharmaceuticals, which is one of the world's leading pharma companies. APIL has interests in the six crucial areas of cardiovascular, respiratory, maternal health... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 ASTRAZENECA PHARMA   TEVA PHARMA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-18
TEVA PHARMA
Dec-13
ASTRAZENECA PHARMA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,2782,981-   
Low Rs8832,589-   
Sales per share (Unadj.) Rs228.41,710.6-  
Earnings per share (Unadj.) Rs10.4106.9-  
Cash flow per share (Unadj.) Rs16.3245.1-  
Dividends per share (Unadj.) Rs093.55-  
Dividend yield (eoy) %03.4 0.0%  
Book value per share (Unadj.) Rs98.81,900.2-  
Shares outstanding (eoy) m25.00848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.71.6 290.5%   
Avg P/E ratio x104.226.1 400.0%  
P/CF ratio (eoy) x66.411.4 584.8%  
Price / Book Value ratio x10.91.5 746.3%  
Dividend payout %087.5 0.0%   
Avg Mkt Cap Rs m27,0082,361,672 1.1%   
No. of employees `0001.444.9 3.0%   
Total wages/salary Rs m1,5350-   
Avg. sales/employee Rs Th4,210.932,275.5 13.0%   
Avg. wages/employee Rs Th1,132.20-   
Avg. net profit/employee Rs Th191.12,016.2 9.5%   
INCOME DATA
Net Sales Rs m5,7101,450,623 0.4%  
Other income Rs m1230-   
Total revenues Rs m5,8331,450,623 0.4%   
Gross profit Rs m463397,254 0.1%  
Depreciation Rs m147117,255 0.1%   
Interest Rs m028,493 0.0%   
Profit before tax Rs m438251,506 0.2%   
Minority Interest Rs m01,143 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-165,100 0.0%   
Tax Rs m179-3,071 -5.8%   
Profit after tax Rs m25990,619 0.3%  
Gross profit margin %8.127.4 29.6%  
Effective tax rate %40.8-1.2 -3,345.5%   
Net profit margin %4.56.2 72.6%  
BALANCE SHEET DATA
Current assets Rs m3,209979,745 0.3%   
Current liabilities Rs m2,070854,421 0.2%   
Net working cap to sales %20.08.6 231.0%  
Current ratio x1.61.1 135.2%  
Inventory Days Days7291 79.7%  
Debtors Days Days3596 36.4%  
Net fixed assets Rs m790473,805 0.2%   
Share capital Rs m503,571 1.4%   
"Free" reserves Rs m2,4190-   
Net worth Rs m2,4691,611,367 0.2%   
Long term debt Rs m0741,736 0.0%   
Total assets Rs m4,6053,315,138 0.1%  
Interest coverage xNM9.8-  
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x1.20.4 283.3%   
Return on assets %5.63.6 156.6%  
Return on equity %10.55.6 186.6%  
Return on capital %17.74.9 359.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-1,7150-   
CASH FLOW
From Operations Rs m88231,154 0.0%  
From Investments Rs m-94-81,907 0.1%  
From Financial Activity Rs mNA-277,285 0.0%  
Net Cashflow Rs m-6-128,038 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.41 Rs / USD

Compare ASTRAZENECA PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare ASTRAZENECA PHARMA With: TTK HEALTHCARE  PFIZER  JUBILANT LIFE SCIENCES  STERLING BIOTECH  WYETH LTD  



Today's Market

Moody's GDP Growth Forecast, Slump in Equity Mutual Fund Inflows, and Top Cues in Focus Today(Pre-Open)

India share markets witnessed selling pressure during closing hours yesterday and ended on a negative note.

Related Views On News

ASTRAZENECA PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 236.5% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 215 m (up 236.5% YoY). Sales on the other hand came in at Rs 2 bn (up 26.7% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 204.9% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, ASTRAZENECA PHARMA has posted a net profit of Rs 98 m (up 204.9% YoY). Sales on the other hand came in at Rs 2 bn (up 26.3% YoY). Read on for a complete analysis of ASTRAZENECA PHARMA's quarterly results.

ASTRAZENECA PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Mar 29, 2019 | Updated on Mar 29, 2019

Here's an analysis of the annual report of ASTRAZENECA PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ASTRAZENECA PHARMA. Also includes updates on the valuation of ASTRAZENECA PHARMA.

More Views on News

Most Popular

Buy this 'Crorepati Stock' and You Could End Up Stinking Rich (Profit Hunter)

Feb 5, 2020

I'm talking about an individual small cap stock that could go up so many times that they make their investors stinking rich in the process. You definitely want to know more...

This Smallcap Stock Could be the Next Titan (Up 1,400% in 10 Years) (Profit Hunter)

Feb 11, 2020

A blueprint to latch on to the next 'Crorepati' stock - and an event I hope you won't miss on any account.

Will Your Trade Go Up or Down Today? (Fast Profits Daily)

Feb 5, 2020

How you can find out which way your trade is likely to move on any given trading day.

Will Algo Traders Take Away All Your Profits? (Fast Profits Daily)

Feb 11, 2020

How to fight back against algo trading systems.

No Change in My Long-Term View on the Rebirth of India Stocks (The 5 Minute Wrapup)

Feb 6, 2020

Why the recent post budget volatility has not affected my bullish view on the Rebirth of India stocks.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Guide on How to Profit from Sensex 100,000.
7 Stocks to Ride the Coming Rebirth of India Rally. Full Details Here...
A Guide to some of the Most Lucrative Stocks in the Market. Download For Free!
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Revealed: Top 7 Stocks to Consider Buying Right Now...

ASTRAZENECA PHARMA SHARE PRICE


Feb 17, 2020 (Close)

TRACK ASTRAZENECA PHARMA

  • Track your investment in ASTRAZENECA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ASTRAZENECA PHARMA

ASTRAZENECA PHARMA 8-QTR ANALYSIS

COMPARE ASTRAZENECA PHARMA WITH

OTHER USEFUL LINKS

MARKET STATS